- After a small pullback in growth during the heart of the COVID pandemic, Semler’s sales, margins and earnings roared back to record levels in Q4 2020.
- More growth is on the way, early indications suggest another record year in 2021, with significant additional opportunities in 2022 and beyond.
- With a strong business model in place, the company has become a cash generating machine and now sports EBITDA margins north of 50%.
- A Future uplisting to the NASDAQ will significantly increase visibility and may “light shares on fire”.
For further details see:
Semler Scientific - Dominating Its Niche, Growing Rapidly And Strengthening Profitability